Prothena Corporation plc
(PRTA - NASDAQ)
8,29 USD
📋 Profilo Aziendale

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation.

|